# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-274554
Filing Date
2025-11-10
Accepted
2025-11-10 17:12:54
Documents
97
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | agen-20250930.htm iXBRL | 10-Q | 3236229
2 | EX-10.1 | agen-ex10_1.htm | EX-10.1 | 132617
3 | EX-10.2 | agen-ex10_2.htm | EX-10.2 | 65839
4 | EX-10.3 | agen-ex10_3.htm | EX-10.3 | 100043
5 | EX-31.1 | agen-ex31_1.htm | EX-31.1 | 17116
6 | EX-31.2 | agen-ex31_2.htm | EX-31.2 | 17205
7 | EX-32.1 | agen-ex32_1.htm | EX-32.1 | 11948
| Complete submission text file | 0001193125-25-274554.txt |  | 13210300

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | agen-20250930.xsd | EX-101.SCH | 1638759
100 | EXTRACTED XBRL INSTANCE DOCUMENT | agen-20250930_htm.xml | XML | 2542519

Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 251467363
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)